3,233 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

INSM

Insmed
US$26.382.8%39.2%US$3.9bUS$44.20PS12.4xE38.0%n/a

DESN

Dottikon ES Holding
CHF253.504.1%12.4%CHF3.5bn/aPE40.5xn/a0%

TPTX

Turning Point Therapeutics
US$76.011.3%18.9%US$3.8bUS$76.00PS3776xE24.7%n/a

ALVO

Alvotech
US$13.60-6.3%45.6%US$3.8bUS$16.50PS40.7xE95.2%n/a

600518

Kangmei Pharmaceutical
CN¥1.96-1.5%-18.3%CN¥27.2bn/aPE169.4xn/a0%

HYPE3

Hypera
R$30.392.0%-19.4%R$19.3bR$41.12PE11.3xE13.6%4.1%

IOVA

Iovance Biotherapeutics
US$13.454.4%79.3%US$3.7bUS$26.00PS3165.5xE61.7%n/a

RYZB

RayzeBio
US$62.490%n/aUS$3.7bUS$53.33PB6.5xE2.0%n/a

CBAY

CymaBay Therapeutics
US$32.480.03%262.9%US$3.7bUS$32.50PS120xE54.8%n/a

600521

Zhejiang Huahai Pharmaceutical
CN¥18.248.9%0.7%CN¥26.7bCN¥18.17PE28.8xE24.2%1.1%

GXI

Gerresheimer
€99.15-2.4%-0.6%€3.4b€132.89PE29.2xE20.4%1.3%

1877

Shanghai Junshi Biosciences
HK$12.981.2%-53.3%HK$28.4bHK$24.62PS7.3xE26.7%n/a

4536

Santen Pharmaceutical
JP¥1,548.001.2%33.7%JP¥563.4bJP¥1,767.00PE20.3xE7.0%2.1%

HCM

HUTCHMED (China)
UK£3.389.0%44.4%UK£2.9bUK£4.29PE35.9xE17.5%n/a

AJANTPHARM

Ajanta Pharma
₹2,409.657.9%90.0%₹300.9b₹2,440.10PE36.9xE13.3%1.5%

BHVN

Biohaven
US$41.363.7%199.3%US$3.6bUS$57.89PB8.5xE13.8%n/a

AXSM

Axsome Therapeutics
US$73.68-0.7%-5.5%US$3.6bUS$123.56PS13.9xE65.1%n/a

2262

Jiangsu Nhwa Pharmaceutical
CN¥25.652.6%-3.6%CN¥25.8bCN¥32.21PE24xE19.5%1.2%

9995

RemeGen
HK$32.307.7%-19.8%HK$27.6bHK$41.98PS12.9xE55.9%n/a

688114

MGI Tech
CN¥61.515.7%-23.9%CN¥25.3bCN¥83.09PS9xE111.9%0%

SMMT

Summit Therapeutics
US$4.7817.7%148.3%US$3.5bUS$7.50PB75.9xS68.3%n/a

PBH

Prestige Consumer Healthcare
US$70.32-1.3%20.5%US$3.5bUS$74.33PS3.1xE34.5%n/a

RARE

Ultragenyx Pharmaceutical
US$41.22-4.6%-12.5%US$3.5bUS$89.00PS7.7xE49.0%n/a

1548

Genscript Biotech
HK$12.581.9%-37.7%HK$26.7bHK$28.85PS4.1xE92.5%0%
Page 9 of 135
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.